HDL lipidomic analysis in patients with type 2 diabetes mellitus receiving fixed-dose combination of insulin degludec and liraglutide

Autor:	V. Tsimihodimos, Eleni Pappa, E. Vavli, C. Kostara, Eleni Bairaktari
Rok vydání:	2020
Předmět:	Insulin degludec medicine.medical_specialty Endocrinology business.industry Liraglutide Internal medicine Fixed-dose combination Medicine Type 2 Diabetes Mellitus In patient Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	Atherosclerosis. 315:e65
ISSN:	0021-9150
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::abf7a69fae4c21170930c7ab8426f6df https://doi.org/10.1016/j.atherosclerosis.2020.10.200 Zobrazit plný text záznamu Full Text from ScienceDirect